This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

21/504 Amiodarone vs beta blockade for new onset atrial fibrillation in adult intensive care

 

Contact

Supporting Information

*Please note: This document is to be used as a guide and to assist with completion of the on-line application form only, for example to see how many characters are accepted in each section and how the printed complete form is laid out. Please do not try to use this as an application form, you must apply using the online form available through the links available when calls are open. You should also refer to the application form guidance notes.

Study Within A Trial

  • This funding opportunity is eligible for researchers to embed a study within a trial. These studies should evaluate alternative ways of undertaking a trial process.

The Health Technology Assessment Programme is preparing to accept stage 1 applications to its commissioned workstream for this primary research topic. The call will open 29 April 2021, however, potential applicants are invited to start working on applications based on the commissioning brief linked below. The Word version of the application form may be helpful – please see link on the right of the page. Applicants are advised to check this advert regularly for an update on the call opening date. The link to the application form will be available once the call opens.

In order to apply you will need to carefully review the:

Applications received by the advertised closing date will be considered at a first-stage funding committee meeting, and successful applicants will then be invited to submit a stage 2 application. Applicants will have eight weeks to complete and submit their stage 2 application form, which will then be considered at the following HTA funding committee meeting. For more information, please read the commissioning brief.